Loading…
← CockpitCompetitor Analysis › MPT Medical Properties Trust, Inc.Open in the cockpit ↗

Medical Properties Trust, Inc.MPTCompetitor analysis, valuation and peers

United States · USD·Real Estate›Real Estate Investment Trusts

Net-lease REIT that owns hospital buildings and leases them back to hospital operators nationwide and abroad.

Momentum laggard 2
Mkt cap
$1.08B
US dollars, full cap
Free float
82%
of shares outstanding
$/day
$50.4M
20-day average traded
P/B
0.23×
price to book
ROE
5.3%
delivered
Implied ROE
5.2%
what the price asks
Next earnings
111 days
25 Feb 2027
Close · USD$1.81
1D-3.7%
1W-19.6%
1M-43.3%
3M-56.4%
6M-65.0%
YTD-63.8%
1Y-62.8%
ATR %10.0%
Beta0.72
52w lowhigh72.0% off high

What Medical Properties Trust does

Net-lease REIT that owns hospital buildings and leases them back to hospital operators nationwide and abroad.

Collects rent under long-term leases in which the hospital operator pays property costs, so income is only as reliable as the operators' ability to pay. A small number of operators have supplied a large share of rent, and the 2024 bankruptcy of Steward Health Care, a major tenant, forced it to re-lease or sell hospitals.

Products and services

  • Hospital sale-leaseback ownership
  • Loans to hospital operators

Customers

  • For-profit and non-profit hospital operators

Where it sits in the supply chain

  • Real estate
  • Healthcare REITs
  • Acute-care hospital real estate

What could go right

  • Re-leasing vacated hospitals to new operators

What could go wrong

  • Tenant concentration and bankruptcy risk
  • High leverage, dividend cut history

Moat: none (switching costs). Tenant financial health drives rent collection; recent operator bankruptcies (Steward) exposed the model's fragility.

Headquarters: Birmingham, Alabama, US · Founded: 2003 · Employees: 121

Named competitors

Medical Properties Trust at a glance

Size Medical Properties Trust (MPT) is a United States Real Estate company (Real Estate Investment Trusts) with a market value of $1.08B, the 2198th largest of 3,117 United States companies the cockpit tracks. Shares closed at $1.81 on 6 Nov 2026.

Performance Over six months the shares fell 65.0%, against -13.3% for the median peer and -1.1% for the United States market (cap-weighted) — lowest of 21 in its peer set.

Growth Revenue grew 10.5% over the last twelve months (peer median +1.2%); the operating margin is 58.3% (peer median 43.8%).

Valuation It trades at 0.23× book value against a peer median of 0.80× (cheapest of 21).

Price implies The share price implies a return on equity of about 5.2%; Medical Properties Trust delivers 5.3%, so the price asks less than the business earns today.

Short interest Short interest is 25.0% of the free float (15 Oct 2026).

Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).

Relative performance

40608010011 May 202611 Aug 20266 Nov 2026Peer median 88MPT 36
Six months, rebased to 100: Medical Properties Trust against the median of its 20 peers (local-currency closes).

Medical Properties Trust financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.03B$972M$996M$872M$1.54B
Revenue growth—-2%+14%-43%—
Gross profit$713M$670M$521M$227M$1.16B
EBITDA$878M$658M$285M$685M$1.34B
Net income$248M-$278M-$2.41B-$558M$901M
Free cash flown/a$231M$245M$506M$739M
Capital expendituren/a$216M$262M$529M$1.54B
Total debt$9.26B$9.77B$8.93B$10.2B$10.4B

Quarterly statements and history in the cockpit →

Medical Properties Trust competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%-40%-20%0%GOZDEA89568957AREIT8966WPRSKGNHP395400LADR07788986MPT6-month return →1-month return →
Up and to the right = strong over both horizons. Medical Properties Trust is the large dot.

Fundamentals: return on equity against price-to-book

-5%0%5%10%15%0.50×10×GOZDEA89568957AREIT8966WPRSKGNHP8987CY6UOPG0778H13CSRWHA8986MPTReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Medical Properties Trust is the large dot.

Capital: ROE delivered against the ROE the price implies

-5%0%5%10%15%0%10%GOZDEA89568957AREIT8966WPRSKGNHP395400LADRCY6UOPG0778H13CSRMPTROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Medical Properties Trust is the large dot.

Medical Properties Trust competitors and peer comparison

Head to head with its named competitors (MPT vs VTR vs DOC vs OHI)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Medical Properties Trust MPT$1.08B-65%+11%5%0.23×5.2%
Ventas VTR$47.9B+2%+22%2%2.97×20.2%
Healthpeak Properties DOC$14.3B+4%+9%5%1.78×15.1%
Omega Healthcare Investors OHI$14.6B+2%+14%14%2.66×15.3%
Welltower WELL$180B+15%+39%4%3.69×24.4%

How Medical Properties Trust compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Medical Properties Trust against its 20 peers (data as of 6 Nov 2026)
MeasureMPTPeer medianRank in peer set
1-month return-43.3%-0.6%lowest of 21
6-month return-65.0%-13.3%lowest of 21
Return on equity5.3%6.3%7th lowest of 20
Price / book0.23×0.80×cheapest of 21
Trailing P/E4.4×13.4×2nd cheapest of 17
ROE the price implies5.2%5.7%8th least demanding of 21
ROE delivered5.3%6.3%7th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Medical Properties Trust MPTUnited States$1.08B-65%+11%5%0.23×5.2%5.3%
Growthpoint Properties Australia GOZ.AXAustralia$1.09B-2%0%4%0.69×8.7%3.9%
Easterly Government Properties DEAUnited States$1.06B-4%+11%1%0.82×8.6%1.0%
NTT UD REIT Investment 8956.TJapan$1.06B-16%+14%6%1.15×4.8%6.1%
TOKYU REIT 8957.TJapan$1.10B-6%+10%9%1.37×5.2%8.6%
Altareit AREIT.PAFrance$1.06B-9%-20%-5%1.38×7.7%-5.4%
Heiwa Real Estate REIT 8966.TJapan$1.06B-15%+24%8%1.15×5.5%8.4%
Waypoint REIT WPR.AXAustralia$1.05B-2%-1%7%0.80×8.8%6.8%
Storage King SKG.AXAustralia$1.05B-17%0%7%0.64×7.8%6.5%
National Healthcare Properties NHPUnited States$1.11B+8%-1%-5%1.05×16.3%-5.3%
SK REIT 395400.KSSouth Korea$1.04B-30%+15%6%0.73×4.8%5.7%
Ladder Capital LADRUnited States$1.12B-13%+2%7%0.77×8.3%6.7%
Japan Excellent 8987.TJapan$1.04B-13%-18%6%1.09×4.6%6.0%
CapitaLand India Trust CY6U.SISingapore$1.03B-15%-2%16%0.71×5.0%15.7%
Cpi Fim OPG.WAPoland$1.00B-16%-35%11%0.58×5.9%11.1%
Fortune Real Estate Investment Trust 0778.HKHong Kong$1.19B-11%-9%0%0.37×4.5%-0.3%
Ho Bee Land H13.SISingapore$978M-13%+5%3%0.33×2.6%2.7%
Centerspace CSRUnited States$963M-15%+15%12%1.21×10.3%11.7%
Wereldhave WHA.ASNetherlands$956M-15%+10%6%0.79×6.0%6.3%
Ntt Dc REIT NTDU.SISingapore$955M-9%-8%n/a0.80×3.1%n/a
Daiwa Securities Living Investment 8986.TJapan$1.22B-25%+42%7%1.02×5.4%7.1%

Questions

Who are Medical Properties Trust's main competitors?
Named competitors: Ventas (VTR), Healthpeak Properties (DOC), Omega Healthcare Investors (OHI), Welltower (WELL). The cockpit's measured peer set (industry) also includes Growthpoint Properties Australia (GOZ.AX), Easterly Government Properties (DEA), NTT UD REIT Investment (8956.T), TOKYU REIT (8957.T), Altareit (AREIT.PA), Heiwa Real Estate REIT (8966.T).
Is Medical Properties Trust expensive compared with its peers?
On price / book it trades at 0.23× against a peer median of 0.80×, cheapest of 21 in its peer set. The share price implies a return on equity of about 5.2%; Medical Properties Trust delivers 5.3%, so the price asks less than the business earns today.
How has Medical Properties Trust stock performed?
Over six months to 6 Nov 2026 the shares returned -65.0% against -13.3% for the median peer; over one year -62.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.